Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Rebirth of Dermagraft

This article was originally published in Start Up

Executive Summary

Dermagraft is often mentioned as an example of a failure in tissue engineering, illustrating the difficulty of achieving return on investment in this field. The product was only a market failure, however; clinicians say that it worked to heal difficult wounds, and that it was just a product ahead of its time. Now small company Advanced BioHealing has given new life to the bioengineered dermal substitute, abandoned by Smith & Nephew, by supporting it with the focus, and the unique marketing and manufacturing skills that tissue-engineered products require. In the process, it believes it has created assets and skill-sets from which other tissue-engineering start-ups might benefit.
Advertisement

Related Content

Reapplix APS
Biologics: The Growth Engine In Advanced Wound Care
Biologics: The Growth Engine in Advanced Wound Care
Shire Nabs Advanced BioHealing Just Prior To Planned IPO
Renewed Growth In Regenerative Medicine
Medtech Risk Capital? Anything But. A VC Roundtable from IN3
Integra LifeSciences: Mid-Sized Company in Big Company Clothing
Start-Up News February 2008
Scaffolds in Tissue Engineering
Advanced Wound Care: The Device Industry's New Billion Dollar Product Market

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT037545

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel